HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
R Foà Selected Research
R Foà Research Topics
Disease
6
Neoplasms (Cancer)
01/2013 - 10/2001
5
Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2010 - 01/2000
4
Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
12/2017 - 01/2006
3
B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
03/2014 - 12/2004
2
Hemorrhage
07/2015 - 03/2006
2
Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
09/2010 - 10/2001
1
Graft vs Host Disease (Graft-Versus-Host Disease)
07/2022
1
Pneumonia (Pneumonitis)
01/2020
1
Lymphoma (Lymphomas)
02/2015
1
Infections
01/2013
1
Mucormycosis
01/2013
1
Neutropenia
01/2013
1
Virus Diseases (Viral Diseases)
12/2011
1
Leukemia
06/2011
1
Pancytopenia
11/2009
1
Cytopenia
11/2009
1
Viremia
11/2009
1
Ovarian Teratoma
06/2009
1
Disease Progression
03/2006
1
Chronic Disease (Chronic Diseases)
03/2006
1
Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
03/2006
1
Residual Neoplasm
04/2005
1
Hairy Cell Leukemia
10/2001
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL)
04/2001
1
Carcinogenesis
11/2000
1
Colonic Neoplasms (Colon Cancer)
11/2000
1
Microsatellite Instability
11/2000
Drug/Important Bio-Agent (IBA)
2
Transcription Factors (Transcription Factor)
IBA
12/2015 - 02/2015
2
Monoclonal Antibodies
IBA
12/2011 - 10/2001
2
Rituximab (Mabthera)
FDA Link
09/2010 - 10/2001
1
KIR Receptors
IBA
12/2017
1
HLA Antigens (Human Leukocyte Antigens)
IBA
12/2017
1
Factor XI (Plasma Thromboplastin Antecedent)
IBA
07/2015
1
Bendamustine Hydrochloride
FDA Link
03/2014
1
ofatumumab
FDA Link
03/2014
1
Azacitidine (5 Azacytidine)
FDA Link
01/2013
1
posaconazole
FDA Link
01/2013
1
liposomal amphotericin B
FDA Link
01/2013
1
Immunomodulating Agents
IBA
12/2011
1
Proteins (Proteins, Gene)
FDA Link
06/2011
1
plerixafor
FDA Link
06/2011
1
ocrelizumab
IBA
09/2010
1
Cytidine Deaminase
IBA
01/2010
1
Protein Isoforms (Isoforms)
IBA
01/2010
1
Alemtuzumab (Campath)
FDA Link
11/2009
1
Imatinib Mesylate (Gleevec)
FDA Link
07/2009
1
Intravenous Immunoglobulins (IVIG)
FDA Link
06/2009
1
Platelet-Derived Growth Factor beta Receptor (Receptor, Platelet Derived Growth Factor beta)
IBA
01/2008
1
Inosine Triphosphate (ITP)
IBA
03/2006
1
Integrin alpha4beta1 (VLA-4)
IBA
01/2006
1
Daunorubicin (Cerubidine)
FDA Link
Generic
04/2005
1
Immunoglobulins (Immunoglobulin)
IBA
12/2004
1
CD20 Antigens
IBA
10/2001
1
nuclear pore complex protein 98
IBA
04/2001
1
Androgens
IBA
11/2000
1
Androgen Receptors (Androgen Receptor)
IBA
11/2000
1
RNA-Directed DNA Polymerase (Reverse Transcriptase)
IBA
01/2000
Therapy/Procedure
5
Therapeutics
01/2013 - 04/2005
1
Stem Cell Transplantation
07/2022
1
Phototherapy (Light Therapy)
07/2022
1
Drug Therapy (Chemotherapy)
01/2020
1
Immunotherapy
12/2017
1
Treatment Delay
12/2011
1
Intravenous Infusions
11/2009
1
Radiotherapy
02/2005